Company profile

Beacon Biosignals, Inc.

Beacon Biosignals, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on August 18, 2023 and the most recent on November 22, 2024 (Dreem 3S). Its most common review panel is Neurology (3 devices).

3AI devices
2023First decision
2024Latest decision
1Specialties

Per year

2023: 12024: 2
20232024
Beacon Biosignals, Inc. AI devices per year: 2023 1, 2024 2

By specialty

  • Neurology3

Related guides

Top neurology devices

Timeline

  1. Dreem 3S · Neurology · OLZ
  2. SleepStageML · Neurology · OLZ
  3. Dreem 3S · Neurology · OLZ